KarXT, Trimethobenzamide, Ondansetron, Meclizine — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-30 in 2mo
ESTIMATED |
READOUT
Study to Assess Safety and Tolerability of KarXT With Administration of Antiemet
Phase 4 · Healthy Volunteers |
Karuna Therapeutics, Inc., a Brist | KarXT, Trimethobenzamide, Ondansetron, M |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|